Enabling the possibility for a universal
bone marrow transplant solution for patients
with cancers and rare genetic diseases
Novel cellular and
Gamida Cell is committed to changing the treatment paradigm for patients with cancer and rare genetic diseases.
Gamida Cell’s world-class scientists have developed a technology that offers the potential of curative cellular and immune therapeutics for a diverse population of patients in need. The proprietary NAM technology, which harnesses epigenetics to increase the population of functional cells in culture, is utilized to develop a broad pipeline of best-in-class therapies to treat cancer and rare genetic diseases.